Among our study group, younger age at diagnosis (less than 50 years), nulliparity, axillary lymph node metastases, IDC NST, HER2 overexpression, and local recurrence were more prevalent in right-sided breast cancers. This evidence concerns the gene ERBB2 and breast cancer.